INH Direnç Mekanizmaları
Although the precise mechanism of isoniazid (INH) action on Mycobacterium tuberculosis remains poorly understood, the pro-drug INH enters the cytoplasm through simple passive diffusion. It activated by the enzyme catalase/peroxidase encoded by KatG gene. Activation of INH results in the formation o...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dicle University Medical School
2017-09-01
|
Series: | Dicle Medical Journal |
Subjects: | |
Online Access: | http://diclemedj.org/upload/sayi/65/Dicle%20Med%20J-03257.PDF |
id |
doaj-3cbb022e4c38436a94c96947586c6100 |
---|---|
record_format |
Article |
spelling |
doaj-3cbb022e4c38436a94c96947586c61002020-11-25T00:07:04ZengDicle University Medical SchoolDicle Medical Journal 1300-29451308-98892017-09-0144328729210.5798/dicletip. 339020INH Direnç MekanizmalarıTanseli Gönlügür 0Ugur Gönlügü1Çanakkale Devlet Hastanesi Göğüs Hastalıkları Abd. Çanakkale, Türkiye ORCID: 0000 - 0003 - 0751 - 6184Çanakkale 18 Mart Üniversitesi Göğüs Hastalıkları Abd. Çanakkale, Türkiye ORCID: 0000 - 0001 - 8720 - 2788 Although the precise mechanism of isoniazid (INH) action on Mycobacterium tuberculosis remains poorly understood, the pro-drug INH enters the cytoplasm through simple passive diffusion. It activated by the enzyme catalase/peroxidase encoded by KatG gene. Activation of INH results in the formation of various potent free radical species that are capable of disabling many cellular processes such as mycolic acid synthesis. Mutations in katG are the major mechanism of INH resistance. More than 50% of isoniazid-resistant clinical isolates contain a mutation in KatG wherein the serine at position 315 is substituted with threonine. Several other genes such as inhA, ndh, and efflux pump genes may contribute to INH resistance. This review article discusses the mechanisms of action of INH and the molecular basis of drug resistance in M. tuberculosis.http://diclemedj.org/upload/sayi/65/Dicle%20Med%20J-03257.PDFIsoniazidresistancemechanismstuberculosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tanseli Gönlügür Ugur Gönlügü |
spellingShingle |
Tanseli Gönlügür Ugur Gönlügü INH Direnç Mekanizmaları Dicle Medical Journal Isoniazid resistance mechanisms tuberculosis |
author_facet |
Tanseli Gönlügür Ugur Gönlügü |
author_sort |
Tanseli Gönlügür |
title |
INH Direnç Mekanizmaları |
title_short |
INH Direnç Mekanizmaları |
title_full |
INH Direnç Mekanizmaları |
title_fullStr |
INH Direnç Mekanizmaları |
title_full_unstemmed |
INH Direnç Mekanizmaları |
title_sort |
inh direnç mekanizmaları |
publisher |
Dicle University Medical School |
series |
Dicle Medical Journal |
issn |
1300-2945 1308-9889 |
publishDate |
2017-09-01 |
description |
Although the precise mechanism of isoniazid (INH) action on Mycobacterium tuberculosis remains poorly understood, the pro-drug INH enters the cytoplasm through simple passive diffusion. It activated by the enzyme catalase/peroxidase encoded by KatG gene. Activation of INH results in the formation of various potent free radical species that are capable of disabling many cellular processes such as mycolic acid synthesis. Mutations in katG are the major mechanism of INH resistance. More than 50% of isoniazid-resistant clinical isolates contain a mutation in KatG wherein the serine at position 315 is substituted with threonine. Several other genes such as inhA, ndh, and efflux pump genes may contribute to INH resistance. This review article discusses the mechanisms of action of INH and the molecular basis of drug resistance in M. tuberculosis. |
topic |
Isoniazid resistance mechanisms tuberculosis |
url |
http://diclemedj.org/upload/sayi/65/Dicle%20Med%20J-03257.PDF |
work_keys_str_mv |
AT tanseligonlugur inhdirencmekanizmaları AT ugurgonlugu inhdirencmekanizmaları |
_version_ |
1725420100637425664 |